EXHIBIT 10.1
MYRIAD GENETICS, INC. HAS OMITTED FROM THIS EXHIBIT 10.1 PORTIONS OF THE
AGREEMENT FOR WHICH MYRIAD GENETICS, INC. HAS REQUESTED CONFIDENTIAL
TREATMENT FROM THE SECURITIES AND EXCHANGE COMMISSION. THE PORTIONS OF THE
AGREEMENT FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED ARE MARKED
"[ ]" AND SUCH CONFIDENTIAL PORTIONS HAVE BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION.
PATENT AND TECHNOLOGY LICENSE AGREEMENT
This thirteen (13) page AGREEMENT ("AGREEMENT") is made on this 26th day of September, 1996 by and
between the BOARD OF REGENTS ("BOARD") of THE UNIVERSITY OF TEXAS SYSTEM
("SYSTEM"), an agency of the State of Texas, whose address is 201 West 7th Street, Austin, Texas 78701,
THE UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER ("MDA"), a component Institution
of the SYSTEM and Myriad Genetics, Inc., a Delaware corporation having a principal place of business located
at 390 Wakara Way, Salt Lake City, Utah 84108 ("LICENSEE").
TABLE OF CONTENTS
-2-
RECITALS
RECITALS........................................ 3
I. EFFECTIVE DATE............................................ 3
II. DEFINITIONS............................................... 3
III. LICENSE................................................... 4
IV. CONSIDERATION, PAYMENTS AND REPORTS....................... 5
V. PUBLICATION............................................... 8
VI. PATENTS AND INVENTIONS.................................... 8
VII. INFRINGEMENT BY THIRD PARTIES............................. 8
VIII. PATENT MARKING............................................ 9
IX. INDEMNIFICATION........................................... 9
X. USE OF BOARD AND COMPONENT'S NAME......................... 9
XI. CONFIDENTIAL INFORMATION.................................. 10
XII. ASSIGNMENT................................................ 10
XIII. TERMS AND TERMINATION..................................... 10
XIV. WARRANTY